Abnormal Brain Iron Metabolism in Irp2 Deficient Mice Is Associated with Mild Neurological and Behavioral Impairments

• DOI: 10.1371/journal.pone.0098072
• Publication Date: 2014-06-04T20:26:56Z
• Authors: Kimberly B. Zumbr...; Lore Becker; Lillian Garrett; Sabine M. Hölter; Julia Calzada-Wack; Ilona Mossbrugger; Leticia Quintanil...; Ildiko Racz; Birgit Rathkolb; Thomas Klopstock; Wolfgang Wurst; Andreas Zimmer; Eckhard Wolf; Helmut Fuchs; Valerie Gailus-Du...; Martin Hrabě de A...; Steven J. Romney; Elizabeth A. Leibold
• Keywords: Nociception; Science; Iron; metabolism [White Matter]; 610; physiopathology [Brain]; genetics [Receptors, Transferrin]; Motor Activity; metabolism [Oligodendroglia]; Mice; 03 medical and health sciences; pathology [Brain]; pathology [White Matter]; Receptors, Transferrin; Genetics; pathology [Neurons]; Animals; ddc:610; Molecular Biology; Iron Regulatory Protein 2; metabolism [Iron]; genetics [Iron Regulatory Protein 2]; Mice, Knockout; Neurons; 0303 health sciences; Behavior, Animal; Q; Organisms; physiopathology [White Matter]; R; Biology and Life Sciences; Brain; White Matter; physiology [Behavior, Animal]; metabolism [Iron Regulatory Protein 2]; Oligodendroglia; physiology [Motor Activity]; metabolism [Brain]; metabolism [Neurons]; pathology [Oligodendroglia]; Exploratory Behavior; Medicine; metabolism [Receptors, Transferrin]; physiology [Nociception]; Tfrc protein, mouse; Neuroscience; physiology [Exploratory Behavior]; Research Article

Iron Regulatory Protein 2 (Irp2, Ireb2) is a central regulator of cellular iron homeostasis in vertebrates. Two global knockout mouse models have been generated to explore the role of Irp2 in regulating iron metabolism. While both mouse models show that loss of Irp2 results in microcytic anemia and altered body iron distribution, discrepant results have drawn into question the role of Irp2 in regulating brain iron metabolism. One model shows that aged Irp2 deficient mice develop adult-onset progressive neurodegeneration that is associated with axonal degeneration and loss of Purkinje cells in the central nervous system. These mice show iron deposition in white matter tracts and oligodendrocyte soma throughout the brain. A contrasting model of global Irp2 deficiency shows no overt or pathological signs of neurodegeneration or brain iron accumulation, and display only mild motor coordination and balance deficits when challenged by specific tests. Explanations for conflicting findings in the severity of the clinical phenotype, brain iron accumulation and neuronal degeneration remain unclear. Here, we describe an additional mouse model of global Irp2 deficiency. Our aged Irp2-/- mice show marked iron deposition in white matter and in oligodendrocytes while iron content is significantly reduced in neurons. Ferritin and transferrin receptor 1 (TfR1, Tfrc), expression are increased and decreased, respectively, in the brain from Irp2-/- mice. These mice show impairments in locomotion, exploration, motor coordination/balance and nociception when assessed by neurological and behavioral tests, but lack overt signs of neurodegenerative disease. Ultrastructural studies of specific brain regions show no evidence of neurodegeneration. Our data suggest that Irp2 deficiency dysregulates brain iron metabolism causing cellular dysfunction that ultimately leads to mild neurological, behavioral and nociceptive impairments.